Morgan L. McLemore

842 total citations
38 papers, 579 citations indexed

About

Morgan L. McLemore is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Morgan L. McLemore has authored 38 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 20 papers in Genetics and 7 papers in Oncology. Recurrent topics in Morgan L. McLemore's work include Hemoglobinopathies and Related Disorders (13 papers), Blood disorders and treatments (7 papers) and Iron Metabolism and Disorders (7 papers). Morgan L. McLemore is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Blood disorders and treatments (7 papers) and Iron Metabolism and Disorders (7 papers). Morgan L. McLemore collaborates with scholars based in United States, India and Canada. Morgan L. McLemore's co-authors include Daniel C. Link, Jennifer Poursine‐Laurent, Fulu Liu, Satkiran S. Grewal, Angela S. Archambault, Martha Arellano, Elliott F. Winton, Fuad El Rassi, Leon Bernal‐Mizrachi and Marshall S. Horwitz and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Morgan L. McLemore

32 papers receiving 568 citations

Peers

Countries citing papers authored by Morgan L. McLemore

Since Specialization

Citations

This map shows the geographic impact of Morgan L. McLemore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan L. McLemore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan L. McLemore more than expected).

Fields of papers citing papers by Morgan L. McLemore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan L. McLemore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan L. McLemore. The network helps show where Morgan L. McLemore may publish in the future.

Co-authorship network of co-authors of Morgan L. McLemore

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan L. McLemore. A scholar is included among the top collaborators of Morgan L. McLemore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan L. McLemore. Morgan L. McLemore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Langerhans Cell Histiocytosis With Hypothalamic-pituitary and Bone Involvement: A Report of 2 Cases 2025 ·JCEM Case Reports ·(unknown), Jason W. Allen, Morgan L. McLemore, Adriana G. Ioachimescu	0
2	Maternal and Fetal Outcomes in Sickle Cell Disease: Single Center Review 2024 ·Blood ·(unknown), (unknown), Morgan L. McLemore, Ross M. Fasano, Fuad El Rassi	0
3	Enhanced IgG immune response to COVID‐19 vaccination in patients with sickle cell disease 2023 ·British Journal of Haematology ·(unknown), Narayanaiah Cheedarla, Hans Verkerke, (unknown), Shang‐Chuen Wu, Jeanne E. Hendrickson, Andrés Chang, Morgan L. McLemore, Fuad El Rassi, John D. Roback, Andrew S. Neish, (unknown), Sean R. Stowell	5
4	Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999–2020 2023 ·SHILAP Revista de lepidopterología ·(unknown), Patricia Barrett, Betty S. Pace, Morgan L. McLemore, (unknown), (unknown), Ann DiGirolamo, Lindsey L. Cohen, Angela Snyder	8
5	Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity 2023 ·Annals of Diagnostic Pathology ·(unknown), Charles E. Hill, Morgan L. McLemore, Shervin V. Oskouei, Armita Bahrami	0
6	Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease 2019 ·World Journal of Hepatology ·John P. Haydek, (unknown), Rushikesh Shah, Preeti A. Reshamwala, Morgan L. McLemore, Fuad El Rassi, Saurabh Chawla	7
7	Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR) 2019 ·Blood ·Omar Niss, Robert B. Lorsbach, David Buchbinder, Satheesh Chonat, Morgan L. McLemore, Timothy L. McCavit, Jeffrey H. Schwartz, (unknown), Katie Seu, Wenying Zhang, Theodosia A. Kalfa	1
8	Pulmonary Embolism in Sickle Cell Disease: Retrospective Analysis of the Use and Yield of Radiographic Studies 2017 ·Blood ·(unknown), Fuad El Rassi, Morgan L. McLemore	1
9	Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Vamsi Kota, Jee Hyun Kong, Martha Arellano, Fuad El Rassi, Manila Gaddh, Leonard T. Heffner, Elliott F. Winton, Anand P. Jillella, Morgan L. McLemore, H. Jean Khoury	2
10	A 49-Year-Old Man With Cirrhosis and Pulmonary Fibrosis 2016 ·CHEST Journal ·(unknown), Brent P. Little, John P. Norvell, Morgan L. McLemore, Srihari Veeraraghavan	2
11	Genistein Protects Hematopoietic Stem Cells against G-CSF–Induced DNA Damage 2014 ·Cancer Prevention Research ·(unknown), (unknown), (unknown), Ömer Küçük, Michael R. Rossi, Morgan L. McLemore	10
12	Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma 2013 ·Leukemia & lymphoma ·Zahi Mitri, Momin T. Siddiqui, Fuad El Rassi, Jeannine T. Holden, Leonard T. Heffner, Amelia Langston, Edmund K. Waller, Elliott F. Winton, Morgan L. McLemore, Leon Bernal‐Mizrachi, David L. Jaye, Martha Arellano, H. Jean Khoury	16
13	Cerebrospinal Fluid Flow Cytometry in Acute Lymphoblastic Leukemia/Lymphoma: Is It Beneficial?. 2012 ·Blood ·Fuad El Rassi, Zahi Mitri, Leonard T. Heffner, Amelia Langston, Edmund K. Waller, Elliott F. Winton, Morgan L. McLemore, (unknown), Martha Arellano, H. Jean Khoury	1
14	High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years 2011 ·Cancer ·Martha Arellano, Elliott F. Winton, Lin Pan, Lisa Lima, Mourad Tighiouart, Kapil N. Bhalla, Leonard T. Heffner, (unknown), (unknown), Morgan L. McLemore, Amelia Langston, H. Jean Khoury	11
15	Does pretreatment fluorescencein situhybridization forBCR–ABLpredict imatinib-associated hematologic toxicity in chronic myeloid leukemia? 2011 ·Leukemia & lymphoma ·Lisa Lima, (unknown), Sarit Assouline, Debra Saxe, (unknown), Mourad Tighiouart, Morgan L. McLemore, Martha Arellano, Elliott F. Winton, Leon Bernal‐Mizrachi, Jörge E. Cortes, H. Jean Khoury	3
16	Managing Chronic Myeloid Leukemia: A Coordinated Team Care Perspective 2011 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), (unknown), (unknown), (unknown), Morgan L. McLemore, (unknown), Aldemar Montero, (unknown), (unknown), (unknown), (unknown), (unknown), Leonard T. Heffner, Elliott F. Winton, Martha Arellano, H. Jean Khoury	12
17	Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second‐line agents, and beyond 2010 ·Cancer ·Lisa Lima, Leon Bernal‐Mizrachi, Debra Saxe, Karen P. Mann, Mourad Tighiouart, Martha Arellano, Leonard T. Heffner, Morgan L. McLemore, Amelia Langston, Elliott F. Winton, H. Jean Khoury	22
18	Divergent Pathways in COS-7 Cells Mediate Defective Internalization and Intracellular Routing of Truncated G-CSFR Forms in SCN/AML 2008 ·PLoS ONE ·Melissa Hunter, Morgan L. McLemore, Daniel C. Link, (unknown), Alexander Copelan, Belinda R. Avalos	2
19	STAT-3 Activation Is Required for Normal G-CSF-Dependent Proliferation and Granulocytic Differentiation 2001 ·Immunity ·Morgan L. McLemore, Satkiran S. Grewal, Fulu Liu, Angela S. Archambault, Jennifer Poursine‐Laurent, (unknown), Daniel C. Link	179
20	Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. 1998 ·Journal of Clinical Investigation ·Morgan L. McLemore, Jennifer Poursine‐Laurent, Daniel C. Link	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact